Cleveland Research downgraded Bruker (BRKR) to Neutral from Buy.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on BRKR:
- Bruker annouces majority investment in RECIPE Chemicals + Instruments
- Bruker Corporation: Strategic Positioning and Growth Prospects Drive Buy Rating
- China raises tariffs on U.S. goods, banks report Q1 results: Morning Buzz
- Morning Movers: Banks up slightly after first quarter earnings
- Bruker reports preliminary Q1 revenue $795M-$800M, consensus $757.03M